"Capromab pendetide"@en . "* 4 \u00B1 2.1 L"@en . " "@en . "* 42 +/- 22 mL/hr"@en . "Capromab"@en . . . . . "For diagnosis of prostate cancer and detection of intra-pelvic metastases."@en . . "Approximately 10% of the administered radioisotope dose is excreted in the urine during the 72 hours following intravenous infusion."@en . . . "# http://www.google.com/patents/WO2013006706A1?cl=en # http://www.lens.org/lens/patent/US_4671958_A # http://www.google.ca/patents/US4741900 # http://www.google.com/patents/US5162504"@en . . "145464-28-4"@en . "Capromab is a Murine IgG1 monoclonal 7E11-C5.3 antibody that recognizes prostate specific membrane antigen (PSMA \u2013 also known as glutamate carboxypeptidase 2) from prostate cancer cells and normal prostate tissue. It is linked to pendetide, a derivative of DTPA. Pendetide acts as a chelating agent for the radionuclide indium-111. Capromab is used to image the extent of prostate cancer."@en . "In 111 Capromab pendetide"@en . "Binds selectively to cell-surface prostate-specific membrane antigen (PSMA) expressed on prostate tissues and tumors."@en . . . "Humans and other mammals"@en . "approved"@en .